Conversely, changes in the expression of CCL2, CCL5, and CCL21 were linked to tumor stages, influencing tumor growth and metastasis by modulating immune cell activity, thereby highlighting their value as therapeutic targets. This evidence concerns the gene CCL21 and neoplasm.